Comparison

Acelarin European Partner

Item no. TMO-T4060-10mM
Manufacturer TargetMol
CASRN 840506-29-8
Amount 10 mM x 1 mL (in DMSO)
Quantity options 100 mg 10 mM x 1 mL (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Slusarczyk M, et al. Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. J Med Chem. 2014 Feb 27;57(4):1531-42.
Smiles FC1(F)[C@@H](O[C@H](COP(OC2=CC=CC=C2)(N[C@H](C(OCC3=CC=CC=C3)=O)C)=O)[C@H]1O)N4C(=O)N=C(N)C=C4
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias NUC-1031
Shipping condition Cool pack
Available
Manufacturer - Targets
DNA/RNA Synthesis
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
580, 47
Description
Acelarin (NUC-1031) (NUC-1031) is a ProTide enhancement and transformation of the nucleoside analog, gemcitabine.
Bioactivity
Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine.
Pathways
Cell Cycle/Checkpoint|||DNA Damage/DNA Repair
Receptor
DNA synthesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mM x 1 mL (in DMSO)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close